We are investors, entrepreneurs, human resource professionals, scientists, researchers, and physicians committed to identifying unmet needs across the continuum of autism and deploying venture capital to fuel solutions to those needs.
AIF is led by a team with robust experience across the financial, venture capital, and life sciences sectors.
An innovative and patient-oriented scientist, Ashok Srinivasan has an extensive history of leadership in clinical and basic science.
As the Translational Research Scientist for NSABP Foundation/NRG Pittsburgh, Ashok has dedicated the past seven years to translating scientific advances to clinical trials, supporting new technology and therapeutic advancements for breast and colorectal cancer. In this role, Ashok has consulted as a molecular genetics / genomics expert in developing scientific rationales for 10+ clinical trials and educated clinical trialists on emerging trends and best practices in oncology research.
Katie Mangialardi, Principal, invests on behalf of the firm’s Life Sciences and Life Span Services divisions, and has spent her career working at the intersection of healthcare and finance. Katie was previously an Associate at J.P.Morgan, where she worked across both Derivatives Sales and Acquisition Leveraged Finance.
Katie holds a B.S. in Biology of Global Health from Georgetown University, where she was a George F. Baker Scholar. She resides in New York.
Kelly Patterson, Head of Investor Relations & Fund Administration, is responsible for managing all relationship activity, in addition to fund administration, for AIF. Kelly previously worked for 18+ years in the professional sports and entertainment managing key corporate and consumer products partners.
Kelly holds a B.A. in fine arts from Colby College where she played ice hockey. She currently lives in Far Hills, NJ with her husband, newborn son and two dogs.
An innovative and patient-oriented scientist, Ashok Srinivasan has an extensive history of leadership in clinical and basic science.
As the Translational Research Scientist for NSABP Foundation/NRG Pittsburgh, Ashok has dedicated the past seven years to translating scientific advances to clinical trials, supporting new technology and therapeutic advancements for breast and colorectal cancer. In this role, Ashok has consulted as a molecular genetics / genomics expert in developing scientific rationales for 10+ clinical trials and educated clinical trialists on emerging trends and best practices in oncology research.
Katie Mangialardi, Principal, invests on behalf of the firm’s Life Sciences and Life Span Services divisions, and has spent her career working at the intersection of healthcare and finance. Katie was previously an Associate at J.P.Morgan, where she worked across both Derivatives Sales and Acquisition Leveraged Finance.
Katie holds a B.S. in Biology of Global Health from Georgetown University, where she was a George F. Baker Scholar. She resides in New York.
Kelly Patterson, Head of Investor Relations & Fund Administration, is responsible for managing all relationship activity, in addition to fund administration, for AIF. Kelly previously worked for 18+ years in the professional sports and entertainment managing key corporate and consumer products partners.
Kelly holds a B.A. in fine arts from Colby College where she played ice hockey. She currently lives in Far Hills, NJ with her husband, newborn son and two dogs.
Mr. O’Callaghan is Co-Founder & Executive Advisor at the Autism Impact Fund, where he provides expertise in building, empowering and inspiring teams associated with AIF portfolio companies.
Mr. O’Callaghan also founded CPI, a pioneer in the recruiting industry, in 1995. Brian has been involved with several entrepreneurial ventures acting as a founder, investor and advisor including, most recently, AIF.
Dan Tarman has 30+- years of professional and executive experience. Starting his career as a litigation attorney and continuing in the corporate world, has worked at a number of leading companies in senior marketing, brand strategy and corporate communications roles.
Mr. O’Callaghan is Co-Founder & Executive Advisor at the Autism Impact Fund, where he provides expertise in building, empowering and inspiring teams associated with AIF portfolio companies.
Mr. O’Callaghan also founded CPI, a pioneer in the recruiting industry, in 1995. Brian has been involved with several entrepreneurial ventures acting as a founder, investor and advisor including, most recently, AIF.
Dan Tarman has 30+- years of professional and executive experience. Starting his career as a litigation attorney and continuing in the corporate world, has worked at a number of leading companies in senior marketing, brand strategy and corporate communications roles.
Venture capital is the accelerant that brings breakthrough technologies into markets. With millions of kids and adults suffering from severe medical and physiological challenges due to autism, now is the time for the Autism Impact Fund.
